Loading...

Archive

    26 June 2018, Volume 8 Issue 3 Previous IssueNext Issue

    For Selected: Toggle Thumbnails
    Study on the Establishment of an in vitro Blood-Cerebrospinal Fluid Barrier Model
    ZHANG Hai-wei1, ZHANG Dan-shen2, SU Xiao-mei2, ZHAO Kai-yan2, WU Chun-yang1, ZHANG Li1
    2018, 8 (3): 1-8. DOI:10.3969/j.issn.2095-1396.2018.03.001
    Abstract( 153) PDF(7054KB) ( 234)

    Objective:The primary isolated and cultured Sprague-Dawley (SD) rat brain microvascular endothelial cells (BMECs) and astrocyte (As) are established to be an in vitro blood-cerebrospinal fluid barrier(blood-CSF barrier)model that is relatively simple, reliable, reproducible, and nearly in vivo.Methods:BMECs and AS from SD rats were primitively isolated, purified and cultured, and then primitive culture cells were identified by cellular morphological and immunocytochemical staining methods. In vitro blood-CSF barrier model was established by using Transwell culture insert. Model barrier function was evaluated by detection of transendothelial electrical resistance (TEER),4 hours Liquid interview leak test,expression of alkaline phosphatase (ALP) and γ-glutamyl transpeptidase (γ-GT), permeability of sodium fluorescent( Na-FLU). Results:Primary cultured BMECs presented a typical fusiform cobblestone appearance. More than 95% of BMECs were Ⅷ positive. Primary As presented slender synapse and shallower cytoplasm. More than 95% of As were GFAP positive. TEER value for cocultured model group showed (378.97±11.38) Ω·cm2,4-hour liquid leakage test was positive, γ-GT and ALP expressions were (30.88±2.87) μmol·min-1·mL-1 and (2.51±0.88) kingunit· 100 mL-1 respectively,permeability coefficients value of Na-FLU was (2.228±0.85)×106 cm·s-1.Conclusion:The blood-CSF barrier model established in vitro possess in vivo blood-CSF barrier properties in cell morphology,structures and barrier functions.

    References|Related Articles|Metrics
    The Expression of P-Glycoprotein in Neurons and the Effect of Oxidative Stress on P-Glycoprotein
    BAI Ru-bing,ZHANG Zhong-quan,CEN Juan
    2018, 8 (3): 9. DOI:10.3969/j.issn.2095-1396.2018.03.002
    Abstract( 96) PDF(987KB) ( 126)

    P-glycoprotein (P-gp),which is encoded by a multidrug resistance (MDR)gene,is a member of the ATP-binding cassette transporter family. As an important part of the blood-brain barrier (BBB),P-gp is an energy-dependent transporter that blocks the entry of exogenous substances into the cell,and it can also excrete harmful toxic substances in the body. It is a protective barrier of the body. Neurons are the basic units that make up the structure and function of the nervous system. The most obvious pathological changes in many neurological diseases like epilepsy,cerebral ischemia,and neurodegenerative diseases,etc. are the neuronal cells’ injury and apoptosis. Many studies have shown that in some disease states,the expression of P-gp will change,but most of the studies are focused on endothelial cells,and the study of changes in P-gp on neurons is much less. Since oxidative stress is one of the key factors in the occurrence and development of many neurological diseases. This review focuses on the expression of P-gp on neurons and the effect of oxidative stress on P-gp in pathological states.

    References|Related Articles|Metrics
    Neurotoxicity and Prevention of Local Anesthetics in Central Nervous System
    XING Yuan,ZHANG Nan,ZHANG Wei,REN Lei-ming
    2018, 8 (3): 15. DOI:10.3969/j.issn.2095-1396.2018.03.003
    Abstract( 137) PDF(1191KB) ( 259)

    Local anesthetics (LAs) are widely used for caudal,epidural and spinal anesthesia. These drugs manage acute and chronic pain rapidly,however,they are markedly cytotoxic,especially in central nervous system and cardiovascular system. The toxic effects of LAs are dependent on time/dose and usually varies from each other. Recently,many researches focus on the neurotoxicity of LAs. Therefore,we reviewed the neurotoxicity of LAs and prevention of their neurotoxicity.

    References|Related Articles|Metrics
    Advances in Research on Application of Anesthetics and Postoperative Cognitive Dysfunction in Patients
    ZHU Min1, LI Ling-hai2
    2018, 8 (3): 32. DOI:10.3969/j.issn.2095-1396.2018.03.004
    Abstract( 106) PDF(1052KB) ( 230)

    Cognition is the process by which the brain acquires,remembers and processes information. Postoperative cognitive dysfunction (POCD) is a kind of cognitive dysfunction in patients after anesthesia operation and is a common complication after surgery. The clinical manifestations of patients with POCD vary widely,mainly due to impaired short-term memory and executive function,especially short-term memory impairment. In recent years,POCD has been paid more and more attention,and the incidence of POCD among young and old patients,especially those have experienced large surgery,is extremely high. POCD affects postoperative recovery of patients,and early POCD may develop into long-term cognitive impairment,which will seriously affect the quality of life and cause severe economic burden to families and society.Although anesthetic drugs are constantly updated,their performance is constantly optimized,and related monitoring techniques are increasingly improved in anesthetic surgery,the incidence of POCD is still high. So far,there is still no effective method to prevent POCD. This paper summarized the effects and mechanisms of various anesthetic drugs on POCD,and aimed to provide references and new ideas for the implementation of clinical anesthesia programs and the prevention and treatment of POCD.

    References|Related Articles|Metrics
    基础研究(S1-1~10)
    2018, 8 (3): 38.
    Abstract( 93) PDF(1087KB) ( 155)
    Related Articles|Metrics
    临床研究(S2-1~12)
    2018, 8 (3): 45-56.
    Abstract( 77) PDF(1160KB) ( 166)
    Related Articles|Metrics
    其他(S3-1~5)
    2018, 8 (3): 57-62.
    Abstract( 78) PDF(8226KB) ( 110)
    Related Articles|Metrics
    Conference Abstract Index
    2018, 8 (3): 63-64.
    Abstract( 75) PDF(629KB) ( 128)
    Related Articles|Metrics
Baidu
map